Search for: "Novartis Pharmaceuticals Corporation" Results 121 - 140 of 145
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
16 Jun 2015, 7:03 am by sally
Supply & Trading A/S [2015] EWHC 1571 (Comm) (05 June 2015) Thai Airways International Public Company Ltd v KI Holdings Co Ltd & Anor [2015] EWHC 1476 (Comm) (22 May 2015) Mercuria Energy Trading Pte Ltd & Anor v Citibank NA & Anor [2015] EWHC 1481 (Comm) (22 May 2015)   High Court (Technology and Construction Court)   Transformers And Rectifiers Ltd v Needs Ltd [2015] EWHC 1687 (TCC) (12 June 2015) Leeds City Council v Waco UK Ltd [2015] EWHC 1400 (TCC) (22 May 2015) ISG… [read post]
23 Mar 2007, 11:35 am
., Beckman Coulter, Bridgestone Americas, Bristol-Myers Squibb, Cargill Incorporated, Caterpillar, Cephalon, CheckFree, Corning, Dow Chemical, Eastman Chemical, Electronics for Imaging, E.I. du Pont (DuPont), Eli Lilly, ExxonMobil, General Electric, Genzyme, GlaxoSmithKline, Henkel Corporation, Hoffman-La Roche, Johnson & Johnson, Merck, Millennium Pharmaceuticals, Monsanto, Motorola, Novartis, Patent Café.com Inc., Pfizer, Procter… [read post]
27 Dec 2007, 7:09 am
Novartis Pharmaceuticals Corp., 2007 WL 1521138 (D.N.J. [read post]
5 Jan 2011, 9:22 am by Gerald L. Maatman, Jr.
Novartis Pharmaceuticals Corp., Case No. 04-CV-9194 (S.D.N.Y.) following a seven-week trial in the Spring of 2010.  [read post]
19 Oct 2009, 1:24 am
The ruling wipes out verdicts of $33 million against Novartis, $81 million against GlaxoSmithKline, and $215 million (reduced post-trial to $160 million) against AstraZeneca. [read post]
2 Mar 2015, 2:43 pm
ZTE Corporation is ramping up to take advantage of the new legal environment that has resulted from the settlement between Qualcomm and the Chinese National Development and Reform Commission (NDRC) over claims that the company’s licensing practices had violated the country’s Anti-Monopoly Law, recounts Neil.* Groundless threats to sue for IP infringement: the end of an era? [read post]
13 Jul 2016, 8:52 pm by FDABlog HPM
We recently got our hands on a Memorandum prepared by FDA’s Office of Generic Drugs concerning the Agency’s December 3, 2015 approval of Sun Pharma Global FZE’s (“Sun’s”) ANDA 078340 for generic versions of Novartis Pharmaceuticals Corporation’s GLEEVEC (imatinib mesylate) Tablets, 100 mg and 400 mg, that we though was worth sharing with folks. [read post]
26 Jul 2017, 7:24 pm by FDABlog HPM
It was just earlier this month that FDA’s Oncologic Drugs Advisory Committee recommended that FDA approve the first gene therapy product: Novartis Pharmaceuticals Corporation’s BLA 125646 for Tisagenlecleucel for the treatment of pediatric and young adult patients 3 to 25 years of age with relapsed/refractory (r/r) B-cell acute lymphoblastic leukemia. [read post]
7 Jun 2007, 1:17 am
The lawsuit says Christopher Woods sought treatment for the condition, called severe priapism, the day after he bought the nutrition beverage made by the pharmaceutical company Novartis AG at a drugstore and drank it. [read post]
30 Apr 2015, 2:52 am by sally
Court of Appeal (Criminal Division) Moss v The Crown [2015] EWCA Crim 713 (28 April 2015) Raivich v The Queen [2015] EWCA Crim 632 (17 April 2015) Court of Appeal (Civil Division) JG (Jamaica) v Secretary of State for the Home Department [2015] EWCA Civ 410 (29 April 2015) H (A Child) (Analysis of Realistic Options and SGOs) [2015] EWCA Civ 406 (29 April 2015) Whapples, R (on the application of) v Birmingham Crosscity Clinical Commissioning Group & Ors [2015] EWCA Civ 435 (29 April 2015) Curran… [read post]
12 Oct 2007, 7:03 am
Novartis Pharmaceuticals Corp., 2007 WL 2330713, at *4 (S.D. [read post]
2 Jun 2016, 5:23 am by Mary Jane Wilmoth
.; Medical Capital Corporation; Medical Provider Funding Corporation VI; Sidney M. [read post]
27 Apr 2007, 12:04 pm
Yesterday, eighty minutes before the hearing the attendants' line stretched down the corridor with numerous ill-dressed folks lounging on the floor or in chairs ("seat holders" selling their places in line to corporate VP's and lobbyists); those coming later had to sit in an overflow video-feed room; ten or so members of the subcommittee participated in the hearings, some showing significant insight. [read post]